The pharmaceutical landscape is witnessing a change with the introduction of GLP-1 transdermal systems . These cutting-edge formulations offer a promising alternative to delivering glucagon-like peptide-1 https://mollyehbb305229.wssblogs.com/40854163/glp-1-patches-a-novel-way-to-treat-diabetes